"Every Doc will know about (with very little prompting) and prescribe the recombinant product; at some point, the plasma-derived will simply cease to exist."
I realize that cost and supply make the recombinant very attractive but is that the only advantage? Cost and supply aside, what are the advantages and disadvantages of the recombinant product Versus the plasma-derived products?
Perhaps I did not finish my thought (it happens alot). I totally agree with you that plasma will become obsolete. To clarify: At 1st sales may be slow due to familiarity with plasma product, but within 1 - 2 years Atryn will be standard.
Market Data 
Markets 
AI
